LabSense at the GxP Conference 2026

This year, the LabSense team had the opportunity to participate in the GxP Conference organized by the University of Zagreb Faculty of Pharmacy and Biochemistry. It was our first time attending this event, and it proved to be a highly valuable experience.

As a small but important part of the pharmaceutical manufacturing chain, we appreciated the opportunity to hear firsthand about the challenges, experiences, and perspectives of professionals across the industry. The diversity of presentations and workshops provided valuable insights ranging from core GxP topics to digitalization initiatives, AI applications, and the growing importance of data integrity and system security.

Nitrosamine-Related Challenges

We were particularly interested in discussions surrounding nitrosamine-related challenges — an area where we remain committed to supporting the pharmaceutical industry through the analysis of nitrosamines in pharmaceutical products, helping manufacturers determine their actual presence and concentration levels, assess compliance with regulatory requirements, and ultimately ensure the continued safety and quality of medicines for patients.

One key message resonated throughout the conference: every stakeholder in the pharmaceutical supply chain plays a vital role in ensuring the safety, quality, and availability of medicines for patients.

We look forward to future editions and to continuing our contribution to a safer pharmaceutical industry.